E-7386 (CAS No 1799824-08-0) is a novel compound extensively studied in oncology research Originating from cutting-edge pharmaceutical development it functions primarily by modulating the Wnt/ -catenin signaling pathway a crucial target in cancer biology This pathway plays a significant role in cell proliferation and differentiation making E-7386 a promising candidate for targeted cancer therapies In vitro studies have demonstrated its effectiveness in the nanomolar to low micromolar range highlighting its potency E-7386 is frequently utilized in various cell models including tumor cell lines and has shown promising results in preclinical animal studies It is also a valuable tool in drug screening processes aiding researchers in the identification of potential therapeutic agents Experimental concentrations typically depend on the specific research design ensuring tailored applications across diverse scientific investigations